好牧场综合征:一种罕见的病例,呈现出复发性血液溶解
Sai Shankar Mankuzhy Gopalakrishnan1, Remya Raveendran2, Jenikar Paulraj2
1Radiodiagnosis, Shri Sathya Sai Medical College and Research Institute, Chengalpattu, Tamilnadu, India vanhelsing250@gmail.com.
BMJ case reports
|January 3, 2024
概括
善牧综合征是一种自身免疫性疾病,表现为脏和肺部出血. 早期诊断和血交换和免疫抑制剂的治疗迅速改善了一个年轻的患者.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 善牧综合征是一种罕见的自身免疫性疾病.
- 它通常影响年轻成年人,男性的发病率更高.
- 这种疾病的特征是质隆炎,肺出血和抗GBM抗体.
研究的目的:
- 在一个年轻的成年男性中呈现一个Goodpasture综合征病例.
- 突出早期诊断和及时治疗的重要性.
- 为了证明特定治疗方案的有效性.
主要方法:
- 临床表现为疲劳,高血压,血栓塞,呼吸障碍和尿量减少.
- 在临床,血清学 (抗GBM抗体) 和放射学发现的帮助下进行诊断.
- 治疗包括血交换,高剂量的甲基前尼索隆和环胺.
主要成果:
- 患者在早期阶段被诊断出来.
- 在治疗后观察到快速的临床改善.
- 观察到抗GBM抗体标位和蛋白尿的显著下降.
结论:
- 早期诊断Goodpasture综合征对于有效管理至关重要.
- 包括血交换和免疫抑制剂在内的联合治疗可以导致快速恢复.
- 及时干预可以阻止疾病的进展并改善患者的治疗结果.
相关概念视频
Pneumothorax-II
155
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
155
Pulmonary Tuberculosis II
240
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
240
Pneumonia II: Pathophysiology
279
The pathophysiology of pneumonia involves the following steps:
279
Pneumonia I: Introduction
239
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
239
COPD: Pathogenesis and Clinical Features
279
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
279
Pulmonary Tuberculosis III
332
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
332


